These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23025697)

  • 1. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
    Inamo Y; Ochiai T
    Pediatr Dermatol; 2013; 30(6):e191-3. PubMed ID: 23025697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib treatment of generalized localized scleroderma (morphea).
    Moinzadeh P; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2010 Nov; 63(5):e102-4. PubMed ID: 20950732
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib: a novel treatment approach for generalized morphea.
    Coelho-Macias V; Mendes-Bastos P; Assis-Pacheco F; Cardoso J
    Int J Dermatol; 2014 Oct; 53(10):1299-302. PubMed ID: 24697802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.
    de Masson A; Bouaziz JD; Peffault de Latour R; Wittnebel S; Ribaud P; Rubio MT; Micol JB; Suarez F; Nguyen S; Dalle JH; Yakouben K; Robin M; Xhaard A; Adès L; Bourhis JH; Rybojad M; Bagot M; Socié G
    Blood; 2012 Dec; 120(25):5089-90. PubMed ID: 23243159
    [No Abstract]   [Full Text] [Related]  

  • 5. Juvenile localised scleroderma: a retrospective review of response to systemic treatment.
    Cox D; O' Regan G; Collins S; Byrne A; Irvine A; Watson R
    Ir J Med Sci; 2008 Dec; 177(4):343-6. PubMed ID: 18941862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pediatric localized scleroderma with methotrexate.
    Fitch PG; Rettig P; Burnham JM; Finkel TH; Yan AC; Akin E; Cron RQ
    J Rheumatol; 2006 Mar; 33(3):609-14. PubMed ID: 16511930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
    Zulian F; Vallongo C; Patrizi A; Belloni-Fortina A; Cutrone M; Alessio M; Martino S; Gerloni V; Vittadello F; Martini G
    J Am Acad Dermatol; 2012 Dec; 67(6):1151-6. PubMed ID: 22657157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
    Martínez C
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():69-71. PubMed ID: 21381292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis.
    Bibi Y; Gottlieb AB
    J Am Acad Dermatol; 2008 Oct; 59(4):654-8. PubMed ID: 18571768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of morphea treatments and therapeutic algorithm.
    Zwischenberger BA; Jacobe HT
    J Am Acad Dermatol; 2011 Nov; 65(5):925-41. PubMed ID: 21645943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
    Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J;
    Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
    Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
    Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphea-like plaques, induration of the extremities, and eosinophilia.
    Magro-Checa C; Orgaz-Molina J; Lafèbre SR; Rosales-Alexander JL; Arias-Santiago S; Raya E
    Cleve Clin J Med; 2015 May; 82(5):283-4. PubMed ID: 25973874
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Methotrexate for localized morphea with severe pain: a case report.
    Jeon H; Kim C
    Dermatol Online J; 2011 Dec; 17(12):12. PubMed ID: 22233748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Localized scleroderma (morphea)].
    Bono W; Dupin N
    Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical generalized morphea-like scleroderma presenting deep sclerosis on the fingers.
    Taniguchi Y; Okazaki M; Kagawa T; Nakajima K; Nakajima H; Terada Y
    Mod Rheumatol; 2011 Apr; 21(2):232-4. PubMed ID: 21113639
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired Strabismus in Linear Scleroderma of the Face.
    Martini G; Zannin ME; Rodeghiero F; Dal Pos S; Zulian F
    Acta Derm Venereol; 2019 Sep; 99(10):911-912. PubMed ID: 31197382
    [No Abstract]   [Full Text] [Related]  

  • 20. Localized scleroderma: a clinical study at a single center in Korea.
    Noh JW; Kim J; Kim JW
    Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.